SSTR1 and meningioma: On average, 87.6% of meningiomas expressed this latter (95% CI: 79.1; 96.1) versus 54% for the SSTR-1 subtype (95% CI: 0; 100), 57.1% for the SSTR-3 subtype (95% CI: 24.5; 89.7), 60.3% for the SSTR-4 subtype (95% CI: 26.8; 93.8), and 63.1% for the SSTR-5 subtype (95% CI: 12.2; 100).